Radiopharm Theranostics Limited (AU:RAD) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Radiopharm Theranostics Limited has successfully listed its American Depositary Shares on the Nasdaq Capital Market under the ticker symbol ‘RADX’, marking a significant strategic milestone. This secondary listing aims to enhance the company’s visibility among U.S. and international investors without any associated capital raising. Existing U.S. shareholders currently hold 21% of Radiopharm, and the company continues its focus on developing innovative radiopharmaceuticals for oncology.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- M&A News: Paramount (PARA) Turned Down Apollo Global Management Seven Times
- Ford (NYSE:F) Calls for EV Incentives in the United Kingdom
- Intel’s (NASDAQ:INTC) $8B Payout Catches Workers’ Attention
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
